Revolutionising Head and Neck Cancer Care: The EVEREST-HN Project
Oracle HNCUK is thrilled to support the innovative EVEREST-HN project, a game-changing study led by The Royal Marsden. Now entering its feasibility trial phase, this groundbreaking research is set to transform the way suspected head and neck cancer cases are identified and referred.
At the heart of the project is the development of a symptom-based risk stratification tool—a cutting-edge approach designed to streamline referrals and guide diagnostic decisions.
Why is this study important?
The EVEREST-HN trial could reshape the patient treatment journey by:
- Quickly identifying high-risk patients, ensuring timely access to vital investigations and care.
- Reducing unnecessary diagnostics for low-risk patients, improving efficiency and resource use.
- Transforming treatment pathways to enhance outcomes and improve quality of life for patients and their families.
This is more than just research—it’s a bold step towards a future where every patient gets the right care at the right time.
Get Involved
Is your centre ready to be part of this cutting-edge trial? Join us in shaping the future of head and neck cancer care.
Learn more about the EVEREST-HN project and how to participate: https://www.royalmarsden.nhs.uk/everest-hn/about-everest-hn
Together, we can make a real difference.
Mark Steele – Unforgettable evening of humour, resilience, and personal storytelling.
British comedian Mark Steele and military leader Major General Julian Buczacki are joining forces for an unforgettable evening of humour.
Research Large Grants Programme Opportunity
We’re offering up to £300,000 over three years to support innovative, hypothesis-driven research projects.
12 Days of Christmas Winter Appeal 2024
Counting down 12 days of Christmas with fundraising ideas and keeping in touch with Oracle.
Petition to improve HPV Vaccine Uptake
Petition urges increase to HPV vaccine uptake and reduce preventable cancers caused by HPV.
Seeking Specialists for Late Effects Guidelines
Develop national best practice guidelines for managing late effects of head and neck cancer treatment.